4. • Pharma imports by India were at USD 6.5 billion during FY20. Of this, bulk
drugs and drug intermediates hold the largest share in pharma imports. In
FY20, they accounted for about 53% of the total pharma inbound shipments.
Bulk drugs and drug intermediates can be considered as inputs used in
making of formulations which result in desired therapeutic effect in the
human body
• With respect to API/bulk drugs, the dependency of India on imports is
considerable. About more than 60% of bulk drugs are sourced from other
countries, and in case of certain specific bulk drugs, the import dependence
is 80%-90%. It is to be noted that the dependence of India on China is
significant as India imports more than 65% of the total bulk drugs and drug
intermediates from China
Import of bulk drugs and drug intermediates by India
5. • There are two main types of drug
intermediates called advanced
intermediate and APIs ;APIs, as
aforementioned, are used as
intermediate raw material for the
production of therapeutic drugs.
• These are active ingredients that are
later converted into different forms
such as suspensions, capsules,
tablets and other formulations.
• Therefore, the API itself acts as a
drug.
• Advanced ingredients are the
advanced form of drug intermediates.
• There are several different types of
advance intermediates such as
imatinib intermediates, Capecitabine
intermediates, pemetrexed
intermediates, lenalidomide
intermediates, gemcitabine
intermediates, afatinib intermediates,
nilotinib intermediates, temozolomide
intermediates, pazopanib
intermediates and ibrutinib
intermediates.
Two main types of
Drug intermediates
6. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET DATA BY
APPLICATION
Anti-infectives
Oncology
Cardiovascular and hematopoietic
system
Central nervous system
Respiratory system
Gastrointestinal
Hormonal related disorders
Metabolic disorders
Genito-urinary disorders
Musculo-skeletal disorders
Other Therapeutics Uses